Patents by Inventor Pharis Mohideen

Pharis Mohideen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENHANCED BIOAVAILABILITY OF N-(2,6-BIS(1-METHYLETHYL)PHENYL)-N'-((1-(4-(DIMETHYLAMINO)-PHENYL)CYCLOPENTYL)METHYL)UREA HYDROCHLORIDE
    Publication number: 20220117919
    Abstract: Methods for enhancing the bioavailability of N-(2,6-bis(1-methylethyl)phenyl)-N?-((1-(4-(dimethylamino)phenyl)cyclopentyl)-methyl)urea hydrochloride (ATR-101) through administration with food, and compositions and kits related thereto.
    Type: Application
    Filed: October 29, 2021
    Publication date: April 21, 2022
    Applicant: The Regents of the University of Michigan
    Inventor: Pharis MOHIDEEN
  • ENHANCED BIOAVAILABILITY OF N-(2,6-BIS(1-METHYLETHYL)PHENYL)-N'-((1-(4-(DIMETHYLAMINO)-PHENYL)CYCLOPENTYL)METHYL)UREA HYDROCHLORIDE
    Publication number: 20180200209
    Abstract: Methods for enhancing the bioavailability of N-(2,6-bis(1-methylethyl)phenyl)-N?-((1-(4-(dimethylamino)phenyl)cyclopentyl)-methyl)urea hydrochloride (ATR-101) through administration with food, and compositions and kits related thereto.
    Type: Application
    Filed: July 8, 2016
    Publication date: July 19, 2018
    Inventor: Pharis Mohideen
  • COMBINATION THERAPY FOR TREATING DISORDERS ASSOCIATED WITH EXCESS CORTISOL PRODUCTION
    Publication number: 20160287565
    Abstract: Methods are provided for treatment of disorders associated with excess cortisol production, including, but not limited to, treatment of Cushing's syndrome. Such methods involve administration of a therapeutically effective amount of a combination of: (a) an inhibitor of CYP11B1; and (b) ACAT1 inhibitor N-(2,6-bis(1-methylethyl)phenyl)-N?-((1-(4-(dimethyl-lamino)phenyl)cyclopentyl)-methyl)urea or a salt thereof; or (a) an inhibitor of CYP11B1; (b) an inhibitor of CYP11B2; and (c) ACAT1 inhibitor N-(2,6-bis(1-methylethyl)phenyl)-N?-((1-(4-(dimethyl-lamino)phenyl)cyclopentyl)-methyl)urea or a salt thereof.
    Type: Application
    Filed: April 6, 2016
    Publication date: October 6, 2016
    Inventors: Pharis Mohideen, Julia Christine Owens